antidepressant and appetite-stimulating agent in advanced cancer patients. The Pharmacology of Marihuana. New York: Raven Press. p763-775.
Riedel G, Fadda P, McKillop-Smith S et al. (2009). Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice. British Journal of Pharmacology. 156, p1154-1166.
Russo E. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology 163, p1344-1364.
Russo E. (2006). The Solution to the Medicinal Cannabis Problem. Ethical Issues in Chronic Pain Management. Florida: Taylor & Francis. p165–194.
Russo EB, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006;66: p234–46. PubMed
Russo E, Burnett A, Hall B, and Parker KK. (2005). Agonistic properties of cannabidiol at 5-HT-1a receptors. Neurochemical Research. 30, p1037-1043.
Turner CE, Elsohly MA and Boeren EG. (1980). Constituents of Cannabis sativa L. XVII. A review of the natural constituents. The Journal of Natural Products. 43, p169–234.
Wilsey B et al. (2013). Low dose vaporized cannabis significantly improves neuropathic pain. The Journal of Pain. 14 (2), p136-148.
The Healing Power of Nature
Alternative Medicine. (n.d.). Retrieved January 19, 2019, from https://www.merriam-webster.com/dictionary/alternative medicine#medicalDictionary
2Definition of Naturopathic Medicine. (n.d.). Retrieved January 19, 2019, from https://www.naturopathic.org/content.asp?contentid=59
3Naturopathic Medicine FAQs | Learn More Now. (n.d.). Retrieved January 19, 2019, from https://aanmc.org/naturopathic-medicine/faq/
Wang, C. (n.d.). What Is Holistic Medicine? |Acupuncture and Massage College| Miami, FL. Retrieved January 19, 2019, from https://www.amcollege.edu/blog/what-is-holistic-medicine
4What to Expect from a Naturopathic Doctor. (2015, December 04). Retrieved January 19, 2019, from http://www.thenddc.com/what-to-expect-from-a-naturopathic-doctor/
The Endocannabinoid System Explained by a Nurse
1. I. Lara-Celador, Et al. Using the Endocannabinoid System as a neuroprotective strategy in perinatal hypoxic ischemic brain injury. Neural Regen Res. 2013 Mar 15; 8(8): 731-744. ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
2. Caroline Turcotte. The CB2 receptor and its role as a regulator of inflammation. Cell Mol Life Sci J. 2016; 73(23)4449–4470. ncbi.nlm.nih.gov/pmc/articles/PMC5075023
REFERENCES continued